Close Menu

genome interpretation

The exclusive distribution deal expands the Finnish bioinformatics software company's footprint in the Middle East, Africa, and Asia.

A survey by University of Nebraska researchers found that both specialists and primary care healthcare providers largely interpreted genetic testing results correctly.

The Swiss startup plans to use the funding to support the development of genomic analysis software based on the new MPEG-G compression standard.

In an abstract to be presented at ASHG, Baylor Genetics researchers will discuss how Emedgene's AI-driven platform helped them streamline and standardize sequencing review.

The company will bring its Mastermind genomic search engine to clinical labs in China, where early tests have shown a sharp reduction in VUS search time.

The software, presented at the ISMB/ECCB conference, helps researchers fill in gaps in the human epigenome thanks to 3D deep-learning techniques.

With machine learning and clinical natural language processing, the team has come up with more automated methods to do provisional diagnoses on children with genetic disease.

Emedgene, which makes AI-based, automated genomic interpretation software, will use the Series A funding to expand its US sales operations.

The Philips platform will support oncology testing workflows and helped with the launch of Illumina TruSight Tumor 170 NGS testing at the Florida institute.

Fabric Genomics is providing Diagnomics with clinical decision support technology to help healthcare providers understand variants in the ACMG-59 panel.

Pages

A Harvard University professor has been charged with making false claims regarding funds he received from China, the New York Times reports.

Discover magazine reports that animal dissections might dissuade students from science careers, but that a firm has developed synthetic frogs for dissections.

Nature News reports that a US panel is reviewing current guidelines for federally funded gain-of-function viral research.

In PNAS this week: de novo mutation patterns among the Amish, an alternative RNA-seq method, and more.